Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism

A common malignancy that affects women is breast cancer. It is the second leading cause of cancer-related death among women. Metabolic reprogramming occurs during cancer growth, invasion, and metastases. Functional magnetic resonance (MR) methods comprising an array of techniques have shown potential for illustrating physiological and molecular processes changes before anatomical manifestations on conventional MR imaging. Among these, in vivo proton (1H) MR spectroscopy (MRS) is widely used for differentiating breast malignancy from benign diseases by measuring elevated choline-containing compounds. Further, the use of hyperpolarized 13C and 31P MRS enhanced the understanding of glucose and phospholipid metabolism. The metabolic profiling of an array of biological specimens (intact tissues, tissue extracts, and various biofluids such as blood, urine, nipple aspirates, and fine needle aspirates) can also be investigated through in vitro high-resolution NMR spectroscopy and high-resolution magic angle spectroscopy (HRMAS). Such studies can provide information on more metabolites than what is seen by in vivo MRS, thus providing a deeper insight into cancer biology and metabolism. The analysis of a large number of NMR spectral data sets through multivariate statistical methods classified the tumor sub-types. It showed enormous potential in the development of new therapeutic approaches. Recently, multiparametric MRI approaches were found to be helpful in elucidating the pathophysiology of cancer by quantifying structural, vasculature, diffusion, perfusion, and metabolic abnormalities in vivo. This review focuses on the applications of NMR, MRS, and MRI methods in understanding breast cancer biology and in the diagnosis and therapeutic monitoring of breast cancer.

• Publication year

  2022

• Venue

  Metabolites

• Publication date

  2022-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/metabo12040295PMID 35448482PMCID 9030399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Advance of Magnetic Resonance Elastography in Tumor Diagnosis

  2021cited by this paper
• Correlation of DCE-MRI Perfusion Parameters and Molecular Biology of Breast Infiltrating Ductal Carcinoma

  2021cited by this paper
• Feasibility of Velocity‐Selective Arterial Spin Labeling in Breast Cancer Patients for Noncontrast‐Enhanced Perfusion Imaging

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Imaging breast cancer using hyperpolarized carbon-13 MRI

  2020influential reference
• Hyperpolarized 13C MRI of Tumor Metabolism Demonstrates Early Metabolic Response to Neoadjuvant Chemotherapy in Breast Cancer

  2020cited by this paper
• Identifying unknown metabolites using NMR-based metabolic profiling techniques

  2020cited by this paper
• Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer

  2020cited by this paper
• Consensus-based technical recommendations for clinical translation of renal ASL MRI

  2019cited by this paper
• Breast Cancer Metabolomics Using NMR.

  2019cited by this paper
• Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review

  2019cited by this paper
• Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer

  2019cited by this paper
• Breast cancer Ki-67 expression prediction by digital breast tomosynthesis radiomics features

  2019cited by this paper
• Additive Benefit of Radiomics Over Size Alone in the Distinction Between Benign Lesions and Luminal A Cancers on a Large Clinical Breast MRI Dataset.

  2019cited by this paper
• Contrast‐enhanced MRI for breast cancer screening

  2019influential reference
• Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis

  2019cited by this paper
• Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.

  2019cited by this paper
• Breast MRI: State of the Art.

  2019cited by this paper
• Overview of radiomics in breast cancer diagnosis and prognostication

  2019cited by this paper
• Value of whole breast magnetic resonance elastography added to MRI for lesion characterization

  2018cited by this paper
• Abbreviated MRI of the Breast: Does It Provide Value?

  2018cited by this paper
• A New Challenge for Radiologists: Radiomics in Breast Cancer

  2018cited by this paper
• Application of in vivo MR methods in the study of breast cancer metabolism

  2018cited by this paper
• Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI

  2018cited by this paper
• A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines

  2018cited by this paper
• Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high‐resolution magic angle spinning 1H NMR spectroscopy

  2018cited by this paper
• Breast cancer Ki67 expression prediction by DCE-MRI radiomics features.

  2018cited by this paper
• Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo 1H MR spectroscopy.

  2018cited by this paper
• Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status

  2018cited by this paper
• Metabolic fingerprinting in breast cancer stages through 1H NMR spectroscopy‐based metabolomic analysis of plasma

  2018influential reference
• Can Multi-Parametric MR Based Approach Improve the Predictive Value of Pathological and Clinical Therapeutic Response in Breast Cancer Patients?

  2018cited by this paper
• Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

  2017cited by this paper
• 1H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience

  2017cited by this paper
• Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?

  2017influential reference
• Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer.

  2017cited by this paper
• Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA

  2017cited by this paper
• Breast Tissue Metabolism by Magnetic Resonance Spectroscopy

  2017cited by this paper
• Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA‐MB‐231 cells using 1H HR‐MAS NMR spectroscopy

  2017cited by this paper
• Targeting amino acid metabolism for cancer therapy.

  2017cited by this paper
• Magnetic Resonance Spectroscopy of Breast Cancer for Assessing Early Treatment Response: Results from the ACRIN 6657 MRS Trial

  2017cited by this paper
• Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI

  2017cited by this paper
• A new method to reduce false positive results in breast MRI by evaluation of multiple spectral regions in proton MR-spectroscopy.

  2017cited by this paper
• 1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients

  2017influential reference
• Multiparametric MR Imaging of Breast Cancer.

  2016influential reference
• Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.

  2016cited by this paper
• Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer

  2016cited by this paper
• The Tumor Microenvironment Modulates Choline and Lipid Metabolism

  2016cited by this paper
• Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer

  2016cited by this paper
• Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)

  2016cited by this paper
• Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion

  2016cited by this paper
• Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: Correlations with dominant stroma type.

  2016cited by this paper
• Proton MR spectroscopy of normal breasts: Association of risk factors for breast cancer with water and lipid composition of the breast.

  2016cited by this paper
• Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI

  2016cited by this paper
• Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes

  2016cited by this paper
• The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy

  2016cited by this paper
• Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis

  2016cited by this paper
• Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.

  2016cited by this paper
• Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia

  2015cited by this paper
• Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.

  2015cited by this paper
• Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study

  2015cited by this paper
• Quantitative Non-Gaussian Diffusion and Intravoxel Incoherent Motion Magnetic Resonance Imaging: Differentiation of Malignant and Benign Breast Lesions

  2015cited by this paper
• Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study

  2015cited by this paper
• 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis

  2015cited by this paper
• Radiomics: Images Are More than Pictures, They Are Data

  2015cited by this paper
• Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?

  2015cited by this paper
• Taurine induces the apoptosis of breast cancer cells by regulating apoptosis-related proteins of mitochondria.

  2015cited by this paper
• Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer

  2015cited by this paper
• Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis

  2014cited by this paper
• Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS.

  2014cited by this paper
• Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.

  2014cited by this paper
• Metabolic characterization of triple negative breast cancer

  2014cited by this paper
• An introduction to ASL labeling techniques

  2014cited by this paper
• Intravoxel incoherent motion diffusion‐weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma

  2014cited by this paper
• A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.

  2014cited by this paper
• Characterization of breast tissues by diffusion weighted MR imaging

  2014cited by this paper
• Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer

  2014influential reference
• Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

  2013cited by this paper
• Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis.

  2013cited by this paper
• Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer

  2013cited by this paper
• Magnetic Resonance Metabolic Profiling of Breast Cancer Tissue Obtained with Core Needle Biopsy for Predicting Pathologic Response to Neoadjuvant Chemotherapy

  2013cited by this paper
• Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.

  2013cited by this paper
• Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate

  2013cited by this paper
• Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery

  2013cited by this paper
• Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

  2013cited by this paper
• Hyperpolarized 13C NMR studies of glucose metabolism in living breast cancer cell cultures

  2013cited by this paper
• Glutamine and cancer: cell biology, physiology, and clinical opportunities.

  2013cited by this paper
• Short first-pass MRI of the breast

  2012cited by this paper
• Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: An MRI and in vivo proton MRS study

  2012cited by this paper
• Lactate and glycine—potential MR biomarkers of prognosis in estrogen receptor‐positive breast cancers

  2012cited by this paper
• HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors

  2012cited by this paper
• A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy.

  2012cited by this paper
• The prognostic value of tumour-stroma ratio in triple-negative breast cancer.

  2012cited by this paper
• Correlation of perfusion parameters on dynamic contrast‐enhanced MRI with prognostic factors and subtypes of breast cancers

  2012cited by this paper
• Metabolic phenotyping in clinical and surgical environments

  2012cited by this paper
• MR perfusion imaging using the arterial spin labeling technique for breast cancer

  2012cited by this paper
• Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study

  2012cited by this paper
• Diffusion-weighted imaging of the breast: principles and clinical applications.

  2011cited by this paper
• Diagnostic usefulness of water‐to‐fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: An in vivo 1H MRS study

  2011cited by this paper
• Lactate: a metabolic key player in cancer.

  2011cited by this paper
• Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

  2011cited by this paper

• A classification model for early detection of breast cancer by Raman spectroscopy based on categorical embedding transformer

  2026cites this paper
• The Role of Tumor pH in Breast Cancer Imaging: Biology, Diagnostic Applications, and Emerging Techniques

  2025cites this paper
• Isoflurane anesthesia alters 31P magnetic resonance spectroscopy markers compared to awake mouse brain

  2025cites this paper
• Quantifying Spatiotemporal Heterogeneity of Tumor Metabolism and Vasculature with a Multiparametric Point-of-Investigation Microscope

  2025cites this paper
• Recent advances in computed tomography and magnetic resonance imaging techniques for cancer detection with artificial intelligence and machine learning integration

  2025cites this paper
• Synthesizing whole-body CT images from Dixon MR images using tissue composition prior knowledge and a parametric physical model

  2025cites this paper
• Badania radioizotopowe w ocenie raka sutka: przegląd radiofarmaceutyków i technik

  2025cites this paper
• Predicting sentinel lymph node metastatic burden with intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in clinical early-stage breast cancer patients.

  2025cites this paper
• An Modified RamanNet Model Integrated with Serum Raman Spectroscopy for Breast Cancer Screening

  2025cites this paper
• Longitudinal MRI‐Driven Multi‐Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer

  2025cites this paper
• Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases

  2024cites this paper
• Exploring the Intersection of Geophysics and Diagnostic Imaging in the Health Sciences

  2024cites this paper
• Research Progress on the Diagnostic Value of DCE-MRI Combined with DWI in Breast Cancer

  2024cites this paper
• In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla

  2024cites this paper
• Use of ultra-high performance liquid chromatography-high-resolution mass spectroscopy to profile the metabolites from the serum of patients with breast cancer

  2024cites this paper
• Association between HER2 (Ile655Val) polymorphism with risk of breast cancer: An extensive meta-analysis

  2024cites this paper
• A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction

  2024cites this paper
• Predicting efficacy of neoadjuvant chemotherapy in breast cancer patients with synthetic magnetic resonance imaging method MAGiC: An observational cohort study.

  2024cites this paper
• A comprehensive study on epigenetic signatures to monitor disease progression and the response to therapy in breast cancer

  2024cites this paper
• Nanotechnology in Glioblastoma Therapy: Advances in Drug Delivery Systems and Diagnostic Approaches

  2024cites this paper
• False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features

  2023cites this paper
• Potential Applications of Nanoparticles in Improving the Outcome of Lung Cancer Treatment

  2023cites this paper
• Identification of crucial genes involved in thyroid cancer development

  2023cites this paper
• Label-Free Chemically and Molecularly Selective Magnetic Resonance Imaging

  2023cites this paper
• A classification model for detection of ductal carcinoma in situ by Fourier transform infrared spectroscopy based on deep structured semantic model.

  2023cites this paper
• Breast cancer in young Indian women: factors, challenges in screening, and upcoming diagnostics

  2023cites this paper
• Imaging and Spectroscopic-Based Methods to Understand Cancer Metabolism and Biology

  2023cites this paper
• Future of Breast Radiology.

  2023cites this paper
• Calcium-Sensing Receptor Expression in Breast Cancer

  2023cites this paper
• EVALUATING DIAGNOSTIC VALUE OF MAGNETIC RESONANCE SPECTROSCOPY (MRS) FOR DIAGNOSIS OF MALIGNANT BREAST MASSES

  2022cites this paper
• Artificial Intelligence in Breast Cancer Screening and Diagnosis

  2022cites this paper
• Multinuclear MRI in Drug Discovery

  2022cites this paper
• Machine Learning Algorithms for Breast Cancer Diagnosis: Challenges, Prospects and Future Research Directions

  2022cites this paper